(Q38043263)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22975591%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

title

MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22975591%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

neoplastic stem cells

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22975591%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

H Xia

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22975591%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

publication date

14 September 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22975591%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22975591%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22975591%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22975591%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

723-730

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22975591%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/cgt.2012.58

13 February 2020

exact match

0 references

cites work

The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

An extensive class of small RNAs in Caenorhabditis elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

MicroRNAs in human cancer: from research to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

A microRNA polycistron as a potential human oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

c-Myc-regulated microRNAs modulate E2F1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

Vascular anastomosis using controlled phase transitions in poloxamer gels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

The role of let-7 in cell differentiation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

Micro RNAs as a new therapeutic target towards leukaemia signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

MicroRNAs in acute leukemia: from biological players to clinical contributors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

A miR-centric view of head and neck cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

MicroRNAs: toward the clinic for breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

Implication of miRNA in the diagnosis and treatment of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

Clinical implications of microRNAs in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

miRNAs in lung cancer: large roles for small players

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

miRNA expression and its clinical implications for the prevention and diagnosis of non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

Unique microRNA molecular profiles in lung cancer diagnosis and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

MicroRNAs and esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

MicroRNA dysregulation in gastric cancer: a new player enters the game

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

MicroRNA dysregulation in colorectal cancer: a clinical perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

MicroRNA in colorectal cancer: from benchtop to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

MicroRNAs in colorectal cancer: function, dysregulation and potential as novel biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

MicroRNAs in colorectal cancer metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

Alterations of microRNAs contribute to colon carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

Emerging roles of microRNA in the intracellular signaling networks of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

Clinical potential of microRNAs in pancreatic ductal adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

MicroRNA functional network in pancreatic cancer: from biology to biomarkers of disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

MicroRNA in prostate, bladder, and kidney cancer: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

Complex networks orchestrate epithelial-mesenchymal transitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

Epithelial-mesenchymal transition in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

Aberrant expression of miR-196a in gastric cancers and correlation with recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

miRNA-29b suppresses prostate cancer metastasis by regulating epithelial-mesenchymal transition signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

MIR-99a and MIR-99b modulate TGF-β induced epithelial to mesenchymal plasticity in normal murine mammary gland cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

miR-200a regulates SIRT1 expression and epithelial to mesenchymal transition (EMT)-like transformation in mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

An autocrine TGF-beta/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

The Notch ligand Jagged2 promotes lung adenocarcinoma metastasis through a miR-200-dependent pathway in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

miR-200a-mediated downregulation of ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma cell growth, migration and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

MiR-365 regulates lung cancer and developmental gene thyroid transcription factor 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

MicroRNA 34c gene down-regulation via DNA methylation promotes self-renewal and epithelial-mesenchymal transition in breast tumor-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

Hypomethylation of the hsa-miR-191 locus causes high expression of hsa-mir-191 and promotes the epithelial-to-mesenchymal transition in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

MicroRNAs miR-221 and miR-222: a new level of regulation in aggressive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

TRPS1 targeting by miR-221/222 promotes the epithelial-to-mesenchymal transition in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

miR-194 is a marker of hepatic epithelial cells and suppresses metastasis of liver cancer cells in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

MicroRNA-138 suppresses epithelial-mesenchymal transition in squamous cell carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

Identification of miRs-143 and -145 that is associated with bone metastasis of prostate cancer and involved in the regulation of EMT

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

miR-155 promotes macroscopic tumor formation yet inhibits tumor dissemination from mammary fat pads to the lung by preventing EMT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

MiRNA-205 modulates cellular invasion and migration via regulating zinc finger E-box binding homeobox 2 expression in esophageal squamous cell carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

Involvement of NF-κB/miR-448 regulatory feedback loop in chemotherapy-induced epithelial–mesenchymal transition of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

miR-661 expression in SNAI1-induced epithelial to mesenchymal transition contributes to breast cancer cell invasion by targeting Nectin-1 and StarD10 messengers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

The epidermal growth factor receptor responsive miR-125a represses mesenchymal morphology in ovarian cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

Snail and the microRNA-200 family act in opposition to regulate epithelial-to-mesenchymal transition and germ layer fate restriction in differentiating ESCs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

In vitro generation of human cells with cancer stem cell properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

miR-93 suppresses proliferation and colony formation of human colon cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

MiR-34a targeting of Notch ligand delta-like 1 impairs CD15+/CD133+ tumor-propagating cells and supports neural differentiation in medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGFβR2) in colon cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

Reduced miR-128 in breast tumor-initiating cells induces chemotherapeutic resistance via Bmi-1 and ABCC5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

MicroRNA-451 is involved in the self-renewal, tumorigenicity, and chemoresistance of colorectal cancer stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

MIR-451 and Imatinib mesylate inhibit tumor growth of Glioblastoma stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

MiR-125b is critical for the suppression of human U251 glioma stem cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

CAMTA1 is a novel tumour suppressor regulated by miR-9/9* in glioblastoma stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

ID4 imparts chemoresistance and cancer stemness to glioma cells by derepressing miR-9*-mediated suppression of SOX2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

EMT and stem cell-like properties associated with miR-205 and miR-200 epigenetic silencing are early manifestations during carcinogen-induced transformation of human lung epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

Functional analysis of microRNAs in human hepatocellular cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

Transforming growth factor-β regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

let-7 regulates self renewal and tumorigenicity of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

Double-negative feedback loop between reprogramming factor LIN28 and microRNA let-7 regulates aldehyde dehydrogenase 1-positive cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

miR-495 is upregulated by E12/E47 in breast cancer stem cells, and promotes oncogenesis and hypoxia resistance via downregulation of E-cadherin and REDD1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

The miR-17-92 microRNA polycistron regulates MLL leukemia stem cell potential by modulating p21 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

Loss of brain-enriched miR-124 microRNA enhances stem-like traits and invasiveness of glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

The epithelial-mesenchymal transition generates cells with properties of stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

MiR-21 regulates epithelial-mesenchymal transition phenotype and hypoxia-inducible factor-1α expression in third-sphere forming breast cancer stem cell-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

Prolonged mammosphere culture of MCF-7 cells induces an EMT and repression of the estrogen receptor by microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

MicroRNAs differentially regulated by Akt isoforms control EMT and stem cell renewal in cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

Over-expression of FoxM1 leads to epithelial-mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

miR-200a regulates epithelial-mesenchymal to stem-like transition via ZEB2 and beta-catenin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

Targeting microRNAs in cancer: rationale, strategies and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

Silencing of microRNAs in vivo with 'antagomirs'

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

LNA-mediated microRNA silencing in non-human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

MicroRNA sponges: progress and possibilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

Targeting microRNAs with small molecules: from dream to reality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

Small-molecule inhibitors of microrna miR-21 function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

The promise of microRNA replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

MicroRNAs as oncogenes and tumor suppressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

7 January 2021

Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

7 January 2021

MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

7 January 2021

MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

7 January 2021

The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

7 January 2021

miR-27 promotes human gastric cancer cell metastasis by inducing epithelial-to-mesenchymal transition

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

7 January 2021

Differential regulation of the two RhoA-specific GEF isoforms Net1/Net1A by TGF-β and miR-24: role in epithelial-to-mesenchymal transition.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.58

7 January 2021

Identifiers

DOI

10.1038/CGT.2012.58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22975591%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference